
Cnhy India Private Limited
About Cnhy India Private Limited
Data last updated:
Cnhy India Private Limited was a foreign private limited company based in Thane, Maharashtra, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 October 2018.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2018FTC315191. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It was led by directors Chandrasekaran Hariharan Chitoor and Shilian Liu.
Its last annual general meeting (AGM) was held on 31 December 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office was at 7 1st Floor Goldstar Decent Homes A Wing Near Gcc Club Mira Road East, Thane, Maharashtra, India – 401107.
Company details
Contact details
Cnhy India Private Limited's registered office is in Thane, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered Address7 1st Floor Goldstar Decent Homes A Wing Near Gcc Club Mira Road East, Thane, Maharashtra, India – 401107
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Cnhy India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Cnhy India Private Limited
FY 2019 filings availableFinancial Statement Summary
| Metrics | FY 2018-19 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2018-19 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Cnhy India Private Limited, buy the company report.
Board of directors of Cnhy India Private Limited
Cnhy India has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chandrasekaran Hariharan Chitoor Also directs: Hari Ganesh Pharma Private Limited | Director | 03 Oct 2018 | 8 Years 1 Months | As last reported |
| Shilian Liu Also directs: Shhy India Private Limited | Director | 03 Oct 2018 | 8 Years 1 Months | As last reported |
Legal cases
No court or tribunal cases involving Cnhy India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cnhy India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Cnhy India has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Cnhy India Private Limited, buy the company report.
Recent activity
Cnhy India Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Chandrasekaran Hariharan Chitoor was appointed as Director on 03 Oct 2018.
Frequently asked questions
Cnhy India has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Cnhy India was a foreign private limited company based in Thane, Maharashtra, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 03 October 2018 and is registered under CIN U74999MH2018FTC315191. The company has been struck off by the Registrar of Companies and is no longer operational.
Cnhy India had 2 directors:
- Chandrasekaran Hariharan Chitoor - Director
- Shilian Liu - Director
The CIN (Corporate Identification Number) of Cnhy India is U74999MH2018FTC315191. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Cnhy India is at 7 1st Floor Goldstar Decent Homes A Wing Near Gcc Club Mira Road East, Thane, Maharashtra, India – 401107.
Cnhy India was incorporated on 03 October 2018. It is registered with the Registrar of Companies, Mumbai.
The latest financial statements of Cnhy India on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 31 December 2019. Year-wise statements from FY 2019 are in the company report.
No. Cnhy India has 1 GST registration on record and it is cancelled or inactive.
Cnhy India operated in the pharma industry, in the drug formulation and development segment. It worked in this industry before it was struck off.
Chandrasekaran Hariharan Chitoor was appointed as Director on 03 Oct 2018. Shilian Liu was appointed as Director on 03 Oct 2018.

